IO Biotech (IOBT)
IO Biotech, Inc., a clinical-stage biopharmaceutical company, develops immune-modulating therapeutic cancer vaccines based on the T-win technology platform. The...
- Open
- --
- High
- --
- Low
- --
- Prev. Close
- 0.0480
- Volume
- 0
- Turnover
- 0
- Avg Price
- --
- Bid/Ask Ratio
- --
- Amplitude
- --
- 52wk High
- 2.7900
- Volume Ratio
- 0.00
- Turnover Ratio
- --
IO Biotech Analyst Rating
View moreForecast & Rating
Feb 20, 2026Price forecast
$2.184441.67%
Forecast & RatingHold
4analysts
- Strong buy25.00%
- Buy0.00%
- Hold50.00%
- Sell25.00%
- Strong sell0.00%
News
- Tip Ranks · Apr 16 at 04:18 AM
TD Cowen Sticks to Their Buy Rating for Cannara Biotech (LOVFF)
- prnewswire · Apr 14 at 07:00 PM
20:00 ETSST001, an α-syn PET tracer from Mabwell's incubated company SynuSight Biotech, received NMPA approval to initiate a clinical trial
- biopharmadive · Apr 7 at 09:18 AM
BioOra and Octane Biotech Sign Letter of Intent to Expand Cell Therapy Manufacturing Using the Cocoon® Platform
- benzinga_article · Apr 6 at 07:05 AM
12 Health Care Stocks Moving In Monday's Pre-Market Session
- benzinga_article · Apr 6 at 12:05 PM
12 Health Care Stocks Moving In Monday's Intraday Session
- Tip Ranks · Apr 4 at 09:51 AM
Vikas EcoTech Files SEBI Regulation 74(5) Compliance Certificate for FY 2026
